Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Each batch includes verifiable COA documentation
This serum improves the clarity and texture of the skin, thus encouraging an improved and healthy complexion
Free from caffeine and preservatives
Mechanisms of action of the new antibodies in use in multiple myeloma
Cosentyx (secukinumab) Disease area(s): Immunology Manufacturer(s): Novartis 2024 Sales (USD): $6.14 billion Why it sold so well: In 2024, Novartis Cosentyx registered significant sales growth, with revenues increasing by 23% year-over-year to $6.14 billion
US$ 24.59
US$ 22.28
US$ 25.99
US$ 21.53
US$ 21.17
US$ 22.11
US$ 24.79
US$ 20.25
